Loading
Diagnosis information
Core diagnostic criteria, specifiers, differential considerations, and documentation support in one open, scan-friendly view.
All criteria are shown. No expand controls or hidden sections.
Core criterion A
Intoxication: recent stimulant use; Withdrawal: cessation/reduction after prolonged heavy use
Core criterion B
Intoxication: clinically significant maladaptive behavioural/psychological changes + ≥2 of: tachycardia/bradycardia; pupillary dilation; elevated/lowered BP; sweating/chills; nausea/vomiting; weight loss; psychomotor agitation/retardation; muscular weakness; chest pain; arrhythmia; confusion; seizures/dyskinesias/dystonias; coma; Withdrawal: dysphoric mood + ≥2 of: fatigue; vivid unpleasant dreams; insomnia/hypersomnia; increased appetite; psychomotor retardation/agitation
Core criterion C
Not attributable to another medical condition or better explained by another mental disorder or substance
Consistent with [Stimulant Intoxication] [specifier(s)]. Following recent stimulant use, there have been clinically significant maladaptive behavioural or psychological changes; euphoria; increased energy or alertness; talkativeness; grandiosity; agitation; anxiety; impaired judgement; stereotyped or repetitive behaviours; tachycardia; hypertension; pupillary dilation; sweating or chills, developing during or shortly after substance exposure. The presentation is characterised by direct sympathomimetic effects consistent with the pharmacology of the stimulant. For stimulant withdrawal: following cessation or reduction, there have been dysphoric mood; fatigue; vivid or unpleasant dreams; insomnia; hypersomnia; increased appetite; psychomotor retardation; psychomotor agitation, developing within hours to days after substance reduction or cessation.
Adapt this supplied template to the assessment. It is not a substitute for diagnostic reasoning or local documentation requirements.